University Of Miami School Of Medicine

  • Image

    University of Miami

    The mission of the Miami Clinical and Translational Science Institute (CTSI) is to serve as the home to clinical and translational science at the University of Miami with the goals of: 1) Improving the quality and efficacy of clinical and translational research; 2) Advancing team science, and; 3) Culturalizing health sciences.
  • University of Miami CTSI
    -
    University Of Miami School Of Medicine
    KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Chandylen Nightingale, PhD, MPH from the Wake Forest School of Medicine, hosted by the University of Miami School of Medicine will present her research on “Examining Capacity in Community Oncology and Moving the Needle to Improve Supportive Care Delivery for
  • Nephrotic Syndrome Rare Disease Clinical Research Network III (NEPTUNE)

    Focal and Segmental Glomerulosclerosis, Minimal Change Disease and Membranous Nephropathy, presenting as Nephrotic Syndrome (NS), are a group of rare renal diseases that may cause serious complications and end-stage kidney disease, generating significant individual, societal and economic burdens. The Nephrotic Syndrome Study Network (NEPTUNE) brings together physician scientists at 26 sites in the

  • Inherited Neuropathies Consortium (INC)

    Charcot-Marie-Tooth disease (CMT) is one of the most common inherited neurological disorders, affecting approximately 1 in 2,500 people in the United States. CMT, also known as hereditary motor and sensory neuropathy or peroneal muscular atrophy, comprises a group of disorders that affect peripheral nerves. The Inherited Neuropathy Consortium (INC) is a network of researchers working to find the

  • Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe)

    Amyotrophic lateral sclerosis (ALS) is a fatal disease that involves progressive death of motor nerves in the brain, brainstem and spinal cord. The disease is closely related to disorders such as primary lateral sclerosis, hereditary spastic paraplegia, progressive muscular atrophy and frontotemporal dementia. These diseases have shared genetic causes and underlying biology. They also have in

  • University Of Miami School Of Medicine

    The COVID-19 pandemic, while a significant disruptive event for research, resulted in a novel focus area for clinical and translational (C/T) researchers. Miami CTSI rapidly responded to this critical need by leading a collaborative effort to facilitate COVID-19 research and education initiatives for researchers and community stakeholders, while implementing innovative solutions to continue other

  • University Of Miami School Of Medicine

    The COVID-19 pandemic, while a significant disruptive event for research, resulted in a novel focus area for clinical and translational (C/T) researchers. Miami CTSI rapidly responded to this critical need by leading a collaborative effort to facilitate COVID-19 research and education initiatives for researchers and community stakeholders, while implementing innovative solutions to continue other

  • One of the first synergy papers supported by the CLIC and CTSA consortium was published in the Journal of Clinical and Translational Science. Abstract: A primary barrier to translation of clinical research discoveries into care delivery and population health is the lack of sustainable infrastructure bringing researchers, policymakers, practitioners, and communities together to reduce silos in
  • University Of North Carolina Chapel Hill
    University Of Miami School Of Medicine
    Virginia Commonwealth University

    ReGARDD provides academic researchers with the regulatory tools and resources necessary to successfully navigate the pathway from discovery to clinical implementation of new drugs, biologics and medical devices.

  • University of Miami CTSI
    -
    University Of Miami School Of Medicine

    Please join the University of Miami CTSI for its next Translational Tuesday webinar, a weekly webinar series highlighting UM's top ongoing research and innovations for COVID-19. This webinar will feature a virtual presentation and Q&A with Dr. Natasa Strbo, who will provide a timely overview on efforts to develop a vaccine for the 2019 novel coronavirus SARS-CoV-2, the causative agent of

  • Miami CTSI TT April 14
    -
    University Of Miami School Of Medicine

    Please join us on April 14 at 10 a.m., for Miami CTSI's Translational Tuesday, an online presentation and Q&A with Dr. Erin Kobetz and Dr. Natasha Schaefer Solle, of the University of Miami, who will discuss a new testing effort in collaboration with Miami-Dade County to assess the prevalence of COVID-19 infection in the local community.

  • Logo of the OneFlorida Clinical Research Consortium

    The OneFlorida Clinical Research Consortium represents a strategic integration and expansion of CTSA hub partnerships throughout Florida to create a statewide infrastructure for patient-centered research in diverse health care settings. Consortium partners include the University of Florida, Florida State University, University of Miami and affiliated health care systems, health plans, providers

  • University Of North Carolina Chapel Hill
    Duke University
    Wake Forest University Health Sciences
    Medical University Of South Carolina
    University Of Miami School Of Medicine
    Virginia Commonwealth University
    ReGARDD provides academic researchers with the regulatory tools and resources necessary to successfully navigate the pathway from discovery to clinical implementation of new drugs, biologics and medical devices. Investigational New Drug or Biologic Investigational Device Exemption Educational Videos ReGARDD Sponsored Events Who We Are The Regulatory Guidance for Academic Research of Drugs and
  • The Division of Epidemiology in the Department of Public Health Sciences at the University of Miami is seeking an exceptional candidate for a full-time Associate/Full Professor position who will develop and consolidate a University-wide program in the Epidemiology of Non Communicable Diseases (NCD), in alignment with the Miller School of Medicine research strategic priorities, taking advantage of the intellectual capital throughout the University that addresses the unique diversity of our populations and South Florida's unique location as the gateway to Latin America and the Caribbean.